Preethi Sundaram - Nov 11, 2022 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Strategy Officer
Signature
/s/ Preethi Sundaram
Stock symbol
CPRX
Transactions as of
Nov 11, 2022
Transactions value $
-$618,116
Form type
4
Date filed
11/15/2022, 04:01 PM
Previous filing
Sep 16, 2022
Next filing
Dec 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $312K +56.8K $5.49 56.8K Nov 11, 2022 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$461K -28.4K -50% $16.25 28.4K Nov 11, 2022 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale -$468K -28.4K -100% $16.50 0 Nov 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -56.8K -14.22% $0.00 343K Nov 11, 2022 Common Stock 56.8K $5.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons and not as a result of any disagreement with the Registrant. Dr. Sundaram remains an officer of the Company.